Sponsored Ad | Levenstein Crypto Conference - Leaderboard

Private market investors bet on Hong Kong for IP transactions, biotech exits

Private market investors bet on Hong Kong for IP transactions, biotech exits

(From left to right) Carl Wu, CEO and co-founder of New Frontier Group, moderates a panel in conversation with Trustar Capital’s partner Zhao Yan; Fu Shan, managing partner of Vivo Capital; Gao Meng, chief investment officer of Nan Fung Group; and Leo Zheng, founder & CEO of Lighthouse Capital, at the inaugural From GBA to Global Health Summit in Hong Kong on February 12, 2025. (Photo from New Frontier Group)

Private market investors view Hong Kong as a market with unique strengths for developing health startups, especially in public fundraising and IP transactions, but agree that there is still room for improvement to make it a world-class health centre.

Edited by: Joymitra Rai

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter